bpc 157 hims BPC-157 PURE Delayed Release HIMS jumps more than 7%

HIMS jumps more than 7% after an FDA panel recommends adding BPC 157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer Confirmed: The FDA just moved BPC 157 one step closer to compounded access. This could unleash an entirely new revenue stream. $HIMS BPC 157 Mark Hyman, MD HIMS & Hers shares are trading higher after an FDA advisory panel recommended adding BPC 157 to the 503A compounding list, potentially widening access through licensed pharmacies. Most FDA advisers say peptides like BPC 157 and TB 500 should be made available in the U.S. Here's what happens next. MarketWatch BPC 157 Alphaceuticals by Dr. Catherine

SKU: 89188433464 · From ristorantepizzerianarnali.it